Galmed Pharmaceuticals: 4Q Earnings Snapshot

March 12, 2020 GMT

TEL AVIV, Israel (AP) _ Galmed Pharmaceuticals Ltd. (GLMD) on Thursday reported a loss of $8.3 million in its fourth quarter.

On a per-share basis, the Tel Aviv, Israel-based company said it had a loss of 39 cents.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 37 cents per share.

For the year, the company reported that its loss widened to $20.5 million, or 97 cents per share.

The company’s shares closed at $4.21. A year ago, they were trading at $7.79.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GLMD at https://www.zacks.com/ap/GLMD